The term “genometastasis” is now used by some authors after some successful experiments on malignized normal cells with tumor-derived cfDNA, such as the transfer of the tumor specific KRAS mutation by adding the serum of a CRC patient to a healthy cell line [97]. The gene discussed is KRAS; the disease is colorectal carcinoma.